QA: GRI BIO Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001824293_2023_GRI_BIO_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001824293, GRI BIO Inc.

  xvar xval
0 AssetsCurrent 4,152,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,810,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,758,000
9 ResearchAndDevelopmentExpense 1,170,000
10 remainder_Expenses 122,000
11 remainder_Revenues 0
12 remainder_NetIncome 26,000
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Assets 4,152,000
1 Liabilities 1,810,000
2 Expenses 7,050,000
3 Revenues 0
4 StockholdersEquity 2,342,000
5 NetIncome -7,024,000
6 ComprehensiveNetIncome -7,023,000
7 BaseVar 6,520,000
8 EconomicCapitalRatio -1.00

Edgar->Model Mapping

Feature Distribution

Change over Time